Bio3s

to develop a technology that responds to the demand of consumers who want to collect sarscov-2 samples without pain, bio3s, inc. has a novel "oral and nasal virus clinical collection(ovc) technology", for highly sensitive self-diagnosis of covid-19. the salivfix solution is onestep technology that does not require additional steps such as antigen extract step and rna extraction step in an antigen rapid diagnostic tests (ag-rdts) and pcr analysis, respectively. bio3s, inc. completed clinical trial in comparing the sensitivity and specificity of collecting virus from covid-19 patients' mouth using ovc technology, in comparison to collecting virus with conventional nasopharyngeal swab (nps). we hope our ovc technology leads the self-testing market to diagnosis of respiratory viral infectious disease.